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Background: Pulmonary hypertension (PH) is characterized by arterial vascular remodelling and alteration in
vascular reactivity. Since gap junctions are formed with proteins named connexins (Cx) and contribute to
vasoreactivity, we investigated both expression and role of Cx in the pulmonary arterial vasoreactivity in two rat
models of PH.
Methods: Intrapulmonary arteries (IPA) were isolated from normoxic rats (N), rats exposed to chronic hypoxia (CH)
or treated with monocrotaline (MCT). RT-PCR, Western Blot and immunofluorescent labelling were used to study
the Cx expression. The role of Cx in arterial reactivity was assessed by using isometric contraction and specific gap
junction blockers. Contractile responses were induced by agonists already known to be involved in PH, namely
serotonin, endothelin-1 and phenylephrine.
Results: Cx 37, 40 and 43 were expressed in all rat models and Cx43 was increased in CH rats. In IPA from N rats
only, the contraction to serotonin was decreased after treatment with
37-43Gap27, a specific Cx-mimetic peptide
blocker of Cx 37 and 43. The contraction to endothelin-1 was unchanged after incubation with
40Gap27 (a specific
blocker of Cx 40) or
37-43Gap27 in N, CH and MCT rats. In contrast, the contraction to phenylephrine was decreased
by
40Gap27 or
37-43Gap27 in CH and MCT rats. Moreover, the contractile sensitivity to high potassium solutions was
increased in CH rats and this hypersensitivity was reversed following
37-43Gap27 incubation.
Conclusion: Altogether, Cx 37, 40 and 43 are differently expressed and involved in the vasoreactivity to various
stimuli in IPA from different rat models. These data may help to understand alterations of pulmonary arterial
reactivity observed in PH and to improve the development of innovative therapies according to PH aetiology.
Background
Gap junctions are clusters of intercellular channels
resulting from the connection of two hexameric assem-
bly of membrane proteins termed connexins (Cx) [1].
Each hexameric assembly is also known as a hemichan-
nel or connexon, localized on the membrane of two
adjacent cells and arranged with identical Cx (homo-
meric connexon) or different Cx (heteromeric con-
nexon) with various possible combinations [2]. Such
process has functional consequences and provides an
efficient cellular strategy to finely regulate cell-to-cell
communication. In the vascular wall, the most common
connexins are Cx37, Cx40 and Cx43 in endothelial and
smooth muscle cells [3]. Gap junctions allow cell-to-cell
coupling in between vascular cells of the same type,
namely endothelial or smooth muscle cells but they are
also present in between endothelial and smooth muscle
cells (myoendothelial gap junctions). Gap junctions
allow direct diffusion of ions and small molecules
between adjacent cells in almost all animal tissues. As a
consequence, gap junctions are vital components in the
coordination of vascular response and are therefore
essential for the control of vascular functions including
vasoreactivity and cell proliferation [3]. There is now
accumulating evidence indicating that Cx may play a
role in a variety of vascular diseases including systemic
arterial hypertension [4]. For instance, elevated pressure
has been shown to increase the expression of Cx 43 in
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junctions in pulmonary hypertension (PH) remains lar-
gely unknown.
PH is a multifactorial disease characterized by a pro-
gressive increase in pulmonary vascular resistance
caused by vasoconstriction, vascular cell proliferation
and obliteration of pulmonary microvasculature. These
processes lead to right heart failure and ultimately to
death [6]. PH occurs in a variety of clinical situations
and is associated with a broad spectrum of histological
patterns and molecular abnormalities. Because of this
diversity, early diagnosis is difficult and efficient treat-
ments are still lacking. The recent revision of the classi-
fication of PH distinguishes five groups [7]. Among
these groups, the category 1 PH also known as pulmon-
ary arterial hypertension (PAH) includes idiopathic
PAH, familial PAH and acquired PAH, the latter of
which being associated with other diseases such as HIV
or connective tissue diseases. The non-category 1 PH
previously known as secondary PH includes the category
3 which is a widely distributed PH secondary to alveolar
hypoxia as a result of lung disease such as chronic
obstructive pulmonary disorder (COPD). Although, PH
has progressively evolved from a fatal to a chronic dis-
ease, none of the currently available therapies is curative
[8]. Despite intensive research, PH remains an important
medical challenge and a better knowledge of the under-
lying molecular and cellular mechanisms remains crucial
for the development of new or additional innovative
therapies.
To comprehensively address the issue of the role of gap
junction in PH, we have used two different rat models,
the hypoxia and monocrotaline-induced models that
share pathophysiological characteristics with category
3 and category 1 PH, respectively. Like category 1 and
3 PH patients, monocrotaline- and the chronic hypoxia-
treated rats (MCT and CH rats respectively) exhibit high
circulating concentrations of serotonin (5-HT), endothe-
lin-1 (ET-1) and norepinephrine (an adrenoceptor ago-
nist) [9-14]. These increased concentrations of 5-HT,
ET-1 and norepinephrine participate to the increase in
pulmonary vascular tone [14-16]. Moreover, reduced
expression of a variety of potassium channels and mainly
voltage-gated and calcium-activated potassium channels
leads to membrane depolarisation, voltage-gated calcium
channel opening and cytosolic calcium increase in rat
and patients with PH [15,17]. The resulting intracellular
calcium increase participates to the high pulmonary
arterial vascular tone observed in PH.
In the normal pulmonary arterial wall, we have
recently demonstrated a functional role of gap junctions
in contractile and calcium responses to 5-HT [18]. The
aim of the present study was thus to examine the role
of gap junctions in the abnormal pulmonary arterial
wall in PH. We have demonstrated that Cx 37, 40 and
43 are expressed in intrapulmonary arteries (IPA) from
the normoxic (N), chronic hypoxia (CH) and MCT rats
and that Cx 43 is overexpressed in CH rats. By using
Cx-mimetic peptides as blockers of gap junctions
[18,19], we also highlight the role of Cx in the contrac-
tile responses to stimuli, already known to be involved
in PH, namely 5-HT, ET-1, phenylephrine (an a1-
adrenoceptor agonist, Phe) and depolarising solutions
(high potassium solutions).
Methods
Animal models of PH
Male Wistar rats (300-400 g) were separated into 3
groups: the first group (control or normoxic rats - N
rats) was housed in ambient room air, the second group
(chronic hypoxic rats - CH rats) was exposed to chronic
hypoxia for 3 weeks in a hypobaric chamber (50 kPa)
and the third group was injected with a single intraperi-
toneal dose of monocrotaline (60 mg.kg
-1)( M C Tr a t s )
and used 4 weeks later. MCT (Sigma, St Quentin Falla-
vier, France) was dissolved in an equal volume of HCl
(1 M) and NaOH (1 M). We checked that an injection
of an equal volume of isotonic saline solution did not
modify the pulmonary arterial reactivity to agonists. All
animal care and experimental procedures complied with
the recommendations of the Federation of European
Laboratory Animals Science Association, and were
approved by the local ethics committee (Comité d’éthi-
que régional d’Aquitaine - referenced AP 2/11/2005).
PH was assessed by measuring both the mean pul-
monary arterial pressure (mean PAP) and right ventricle
hypertrophy. To measure PAP, N, CH and MCT rats
were anesthetized with xylazine 10 mg.kg
-1 and keta-
mine 50 mg.kg
-1 by intraperitoneal injection and mean
PAP was measured, in closed-chest rats, through a
catheter inserted in the right jugular vein, then through
the right atria and the right ventricle into the pulmonary
artery, and attached to a Baxter Uniflow gauge pressure
transducer. Pressure was recorded with an automatic
monitor (Physiogard SM 785, ODAM, Wissembourg,
France) [20]. Right ventricle hypertrophy was estimated
by the ratio of right ventricle (RV) to left ventricle plus
septum (LV+S) weight (Fulton’s index).
Tissue Preparation
Rats were sacrificed using CO2 asphyxia according to the
animal care and use local committee (Comité d’éthique
régional d’Aquitaine - referenced AP 2/11/2005). The left
lung was rapidly removed and rinsed in Krebs solution
containing (in mM): 118.4 NaCl, 4.7 KCl, 1.2 MgSO4,2 5
NaHCO3,1 . 2K H 2PO4, 2.5 CaCl2, and 11.1 D-glucose,
pH 7.4 with NaOH. Intrapulmonary arteries with an
external diameter of 300-350 μm (intrapulmonary artery
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artery of the first order - IPA1) were then dissected free
from surrounding connective tissues under binocular
control.
Quantitative RT-PCR
RNA Extraction
IPA from one rat was homogenized using 600 μlo f
Trizol (Invitrogen, Cergy Pontoise, France), then, 120 μl
of chloroform (Sigma, St Quentin Fallavier, France) was
added. RNA was extracted from the aqueous phase after
centrifugation at 15,000 g for 15 min. RNA was precipi-
tated in the presence of isopropanol (Sigma, St Quentin
Fallavier, France) at 20°C overnight. Pure RNA was
obtained by centrifugation at 15,000 g for 15 min and
was washed with 80% ethanol (Sigma, St Quentin Falla-
vier, France). The concentration of RNA was measured
spectrophotometrically by GeneQuant RNA/DNA calcu-
lator (Amersham Pharmacia, Orsay, France). Total RNA
(1 μg) was reverse transcribed into cDNA by using
AMV reverse transcriptase (Promega, Charbonnières-
les-bains, France), RNase inhibitor, and oligo d(T) as a
primer at 42°C for 60 min followed by heating at 94°C
for 3 min.
Real-time Quantitative Polymerase Chain Reaction (PCR)
Real-time quantitative PCR was performed with a Rotor-
Gene 2000 (Corbett Research, Cortaboeuf, France) as
previously described [21]. cDNA from 10 ng of total
RNA were added to 0.2 μl of 50X Titanium Taq DNA
Polymerase combined to its buffer (Clontech Labora-
tories, Saint Germain-en-Laye, France), 1 mM dNTP,
each of the appropriate primer (Sigma Genosys; see
table 1 for concentrations and sequences, St Quentin
Fallavier, France), and 0.5X SYBR Green (Molecular
Probes, Cergy Pontoise, France).
PCR conditions used were identical to those used pre-
viously [18]. PCR negative controls were systematically
made by using water instead of cDNA. All specific pri-
mers were designed by using the primer analysis soft-
ware (Oligo 6.6, Molecular Biology Insights, Cascade,
USA). The efficiency of PCR reactions was always more
than 90%. Specificity of the amplified PCR products was
checked with melting curve analysis and by electrophor-
esis analysis on a 2% agarose gel containing SYBR
Green.
Western Blot
IPA3 from 4 rats were homogenized and proteins were
extracted as previously described [22]. Such protein
extraction from IPA3 was performed from 4 different
pools of 4 rats each. Protein extracts were subjected to
electrophoresis on a 10% acrylamid reducing gel, and
transferred to polyvinylidene fluoride (PVDF) mem-
branes (Immobilon-P, Millipore, Molsheim, France).
The immunoblots were then incubated using rabbit
anti-Cx 37, rabbit anti-Cx 40 or mouse anti-Cx 43
(Zymed, Paris, France) overnight at 4°C. After incuba-
tion with appropriate secondary antibodies coupled to
horseradish peroxydase (HRP, Santa Cruz, Heidelberg,
Germany) for 2 h at room temperature, immunoblots
were then revealed by enhanced chemiluminescence
acquired using Kodak Image Station 4000 MM. Band
densities were quantified using GeneTool software
(SynGene, Cambridge, United Kingdom). Immunoblots
were then stripped and revealed with mouse anti
b-actin.
Table 1 Sequences of the primer pairs (S: sense; AS: antisense) for housekeeping genes (GAPDH, HPRT, PLRPO and
YWHAZ) and genes of interest (Cx 37, Cx 40 and Cx 43) are shown as well as GenBank accession number, product
length, product Tm and concentrations
Gene Sequence GenBank accession number Product length (pb) Product Tm (°C) Concentration (nM)
GAPDH S: ATTCTACCCACGGCAAGTT NM_017008 153 89.4 200
AS: CGCCAGTAGACTCCACGACATA
HPRT S: TGTTGGATATGCCCTTGACTA NM_012583 178 85.6 100
AS: AGATGGCCACAGGACTAGAAC
PLRPO S: AGGTGGGAGCCAGCGAAGC NM_022402 208 91.7 100
AS: GCAACAGTCGGGTAGCCAATC
YWHAZ S: AGCCGAGCTGTCTAACGAG NM_013011 291 88.4 100
AS: GCCAAGTAGCGGTAGTAGTCA
Cx 37 S: GGTGGCAGAGGACGGTCGTCT NM_021654 133 85.3 200
AS: CCATGGTCCAGCCGTAGAGA
Cx 40 S: GGAAAGAGGTGAACGGGAAG NM_01280 197 91.3 200
AS: GGGCCTCGAGACATAACAGTT
Cx 43 S:TCTGCCTTTCGCTGTAACACT NM_012567 117 87.5 200
AS: GGGCACAGACACGAATATGAT
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Immunolabelling of IPA3 isolated from N, MCT and
CH rats was performed as previously described [18].
IPA3 were fixed and cut in 10 μm sections with a cryo-
stat. Sections were first incubated in blocking buffer
containing 0.1% Triton-X100 (Sigma, St Quentin Falla-
vier, France) and 1% bovine serum albumin (BSA) in
PBS for 1 h at room temperature and then in the pri-
mary antibodies (same antibodies as the ones used for
Western Blot) overnight at 4°C. Sections were then
incubated with the appropriate secondary antibodies
coupled to Alexa 546 (Molecular Probes, Cergy Pon-
toise, France). Nuclei were labeled with 45 μMH o e c h s t
33342 (Molecular Probes, Cergy Pontoise, France). Sec-
tions were then observed with a laser scanning confocal
microscope TE2000 (Nikon, Champigny-Sur-Marne,
France) with a × 60, 1.40 NA plan apochromat oil-
immersion objective. Excitation was obtained with a
diode laser at 408 nm to observe nuclei, an argon laser
at 488 nm to observe autofluorescence of the internal
and external elastic lamina and a helium-neon laser at
543 nm to observe Cx labelling. The emitted light was
filtered as appropriate: 450 ± 35 nm for nuclei (blue),
515 ± 30 nm for internal elastic lamina (green), and
605 ± 75 nm for Cx labelling (red).
Isometric tension measurements
IPA1 were divided into short tubular segments with an
external diameter of 1.5-2m ma n du s e df o ri s o m e t r i c
contraction measurement as reported previously [23].
Arterial rings were mounted in isolated organ bath sys-
tems, containing Krebs solution at 37°C and bubbled
continuously with either 15% O2,5 %C O 2 for IPA1 iso-
lated from N and MCT rats, or with 9% O2,5 %C O 2 for
IPA1 isolated from CH rats. As previously determined
[22], an initial load of 0.8 g was applied to arterial rings
isolated from control rats, and 1.6 g to arterial rings iso-
lated from CH and MCT rats. Tissues were allowed to
equilibrate for 1 h in Krebs solution and washed out
every 15 min. A high KCl solution (80 mM) was applied
in order to obtain a reference contraction used to nor-
malize subsequent contractile responses. 80 mM high
KCl solution induced similar contractions in pulmonary
arterial rings from the three rat models (1036 ± 50 mg,
n = 67; 1205 ± 143 mg, n = 64; 953 ± 54 mg, n = 68 in
N, CH and MCT rats respectively; P > 0.05). Contractile
responses to different agonists were then tested by con-
structing a cumulative concentration-response curve
(CCRC) to 5-HT (10 nM to 100 μM ) ,E T - 1( 0 . 1t o
100 nM), Phe (0.1 nM to 10 μM) or high KCl solutions
(4.7 to 100 mM). We inhibited gap junction communi-
cations through Cx 37 and Cx 43 or Cx 40 with
300 μM synthetic connexin-mimetic peptides:
37-43Gap
27 (SRPTEKTIFII; Peptide 2.0 Inc, Shirley, USA),
40Gap
27 (SRPTEKNVFIV; Genscript, Piscataway, USA)
respectively [18,19]. When indicated, peptides were pre-
incubated during 1 h, and then CRC to agonist was per-
formed in the presence of the peptide. Specificity of
these peptides was checked in a previous study [18].
High potassium solutions were obtained by substituting
an equimolar amount of KCl for NaCl from Kreb’s solu-
tion. To determine the role of the gap junctions in con-
ditions close to physiological conditions, we studied the
vessels with intact endothelium. Endothelial function
was tested on each ring by examining the relaxation
induced by 10 μMc a r b a m y l c h o l i n eo n0 . 3μMP h e -
induced preconstricted pulmonary arterial rings. Passive
and active mechanical properties were assessed using
transducer systems, coupled to IOX software (EMKA
technologies, Paris, France) in order to facilitate data
acquisition and analysis [23].
Data analysis and statistics
Results are expressed as mean ± SEM; n indicates the
number of rats for quantitative RT-PCR, Fulton ratio and
mean PAP whereas it indicates the number of experiments
from 4 pools of rats (4 rats per pool) for Western Blot. For
isometric tension measurements, n indicates the number
of pulmonary arterial rings. CCRC to agonists were fitted
using Origin 6 software (Originlab, Paris, France) to the
logistic equation: T = ((T0-Tmax)/(1+(X/EC50)p)) + Tmax
where T, Tmax and T0 are, respectively, the amplitude of
tension developed, the relative maximum and minimal
tensions for a given agonist concentration normalized to
the 80 mM KCl responses, X is the concentration of ago-
nist used, EC50 is the concentration of agonist which pro-
duces half maximal tension, and p is the slope of the
curve. Global comparisons of the CCRC were performed
using ANOVA. When global comparisons of the curves
were significantly different, unpaired Student’s t tests were
performed on maximal effect (Emax) and/or EC50.E C 50
was determined only when the maximal contraction was
achieved. Quantitative RT-PCR results were analyzed with
the GeNorm method [18]. Statistical analyses were per-
formed on all other data using a non parametric test for
unpaired samples (Mann-Whitney test). A value of P <
0.05 was considered significant.
Results
Assessment of pulmonary hypertension in two rat models
The mean PAP value was significantly increased from
15 ± 2 mmHg in N rats (n = 5) to 30.4 ± 1.03 mmHg
in CH rats (n = 5) or 29.8 ± 1.3 mmHg in MCT rats (n
= 5). The Fulton’s index was also significantly increased
in each pulmonary hypertensive rat model indicating a
right ventricle hypertrophy in CH and MCT rats com-
pared to N rats (0.63 ± 0.04, n = 20; 0.54 ± 0.03, n = 20
and 0.27 ± 0.03, n = 20 respectively).
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the endothelial NO-dependent function by inducing a
relaxation with 10 μM carbamylcholine on 0.3 μMP h e -
induced preconstricted pulmonary arterial rings. Relaxation
to carbamylcholine 10 μM was not significantly changed in
CH compared to N rats whereas it was almost abolished in
MCT rats (58.1 ± 3.0% and 3.3 ± 0.9% of the precontrac-
tion to 0.3 μM Phe in CH and MCT rats respectively, n =
48 and 44 vs 64.1 ± 2.9% in N rats, n = 48).
Cx 37, 40 and 43 are expressed in the pulmonary arterial
wall from N, CH and MCT rats
Quantitative RT-PCR and Western Blot experiments have
demonstrated the presence of the mRNA and proteins,
respectively for Cx 37, 40 and 43 in IPA3 from N, CH and
MCT rats (Figure 1A and 1B respectively). Interestingly, a
significant increase in both mRNA and protein levels was
observed for the Cx 43 in IPA3 from CH rats compared to
IPA3 from N rats (Figure 1A and 1B, left panels).
Immunofluorescent labelling studies confirmed the
presence of the Cx 37, 40 and 43 proteins (Figure 2).
The autofluorescence of the external and internal elastic
lamina in green allowed us to delimit the smooth mus-
cle layers from the endothelial cells and the adventitia
as previously observed [18]. The three connexins were
mainly present in the endothelial and possibly in the
myoendothelial junctions (Figure 2). Some punctuate
labelling, characteristic of the Cx staining, was also spar-
sely present for Cx 37 and 40 in the smooth muscle of
IPA3 from N and MCT rats (Figure 2). Since identical
antibodies were used for Western Blot and immuno-
fluorescent labelling experiments, the typical punctuate
labelling observed demonstrate the specificity of these
Cx antibodies and strengthen our Western Blot results.
Comparison of the pulmonary arterial reactivity to
various stimuli in N, CH and MCT rats
We then compared contractile responses to receptor-
dependent or -independent stimuli such as (1) 5-HT,
(2) ET-1, (3) Phe, an agonist of the a1-adrenoceptor and
(4) a depolarising agent such as high potassium solutions
in IPA from N, CH and MCT rats. The contractile
responses to 5-HT and high potassium solutions were
significantly increased in CH rats (Figure 3A and 3D)
whereas those to ET-1 were significantly decreased in
both pulmonary hypertensive rat models (CH and MCT
rats, Figure 3B). Finally, contractile responses to Phe were
significantly increased in MCT rats (Figure 3C).
Role of Cx 37, 40 and 43 in the reactivity to various
stimuli in intrapulmonary arteries from N, CH and
MCT rats
S i n c e ,( 1 )C x3 7 ,4 0a n d4 3a r ea l le x p r e s s e d( F i g u r e1
and 2) and (2) 5-HT, ET-1, Phe and depolarisation
induce a mechanical activity (Figure 3) in intrapulmon-
ary arteries from CH and MCT rats, we systematically
addressed the role of Cx 37, 40 and 43 in the isometric
contraction to 5-HT, ET-1, Phe and high potassium
solutions by using specific blockers of Cx 40 or Cx 37
and 43 (namely
40Gap27 and
37-43Gap27 respectively,
two Cx-mimetic peptides) in IPA from N, CH and MCT
rats.
Contractile responses to 5-HT were significantly
decreased by 300 μM
37-43Gap27 only in IPA from N
rats (Figure 4A). In IPA from either rat model, the con-
tractile responses to ET-1 were unchanged following
one hour incubation with 300 μM
37-43Gap27 or
40Gap27 (Figure 5). Interestingly, and inversely to 5-HT,
contractile responses to Phe were decreased following
300 μM
37-43Gap27 or
40Gap27 treatment in IPA from
CH and MCT rats (Figure 6 B, C and 6D, E respec-
tively). In N rats, contractile responses to Phe were
unchanged by
37-43Gap27 or
40Gap27 incubation (Figure
6A). The effects of the
37-43Gap27 and
40Gap27 on con-
tractile changes from N to CH rats and from N to MCT
rats are demonstrated in figure 6C and 6E respectively.
When using a receptor-independent depolarising
agent (high potassium solutions), contractile responses
were significantly decreased in the presence of 300 μM
37-43Gap27 only in IPA from CH rats (Figure 7B). EC50
was significantly increased in the presence of
37-43Gap27
in IPA from CH rats (40.2 ± 0.5 mM vs 15 ± 1.1 mM in
the absence of
37-43Gap27) indicating a decrease in the
sensitivity to high potassium solutions. 300 μM
40Gap27
had no effect, under identical conditions, in any of the
hypertensive rat models used (Figure 7B and 7D). In the
presence of the
37-43Gap27, the contraction to KCl in
CH rats was identical to the contraction to KCl in N
rats (Figure 7C).
Discussion
Underlying cellular mechanisms as well as targets, gov-
erning the pathogenesis of PH, still remain to be fully
elucidated. This may be due, at least in part, to the fact
that the pathogenesis of PH differs depending on the
type of aetiology of this vascular disorder. For this rea-
son, we conducted the present study in two different
PH models: MCT induced PH (non hypoxic model) and
CH-induced PH (hypoxic model).
Two major excitation-contraction coupling mechan-
isms are involved in regulating pulmonary vascular tone:
electromechanical and pharmacomechanical coupling.
We thus adressed agonist-mediated pulmonary contrac-
tion (pharmacomechanical coupling induced by either
5-HT, ET-1 or Phe) and depolarisation-mediated con-
traction (electromechanical coupling induced by high
potassium solution). In the present study, IPA from CH
rats exhibited hyperreactivity to 5-HT (Figure 3A),
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Regarding ET-1, vasoconstriction to this agent was only
slightly decreased in hypoxic PH whereas it was drama-
tically decreased in MCT-induced PH. In CH rats, pul-
monary arterial contractile responses to ET-1 have been
shown to be increased in resistant IPA but decreased in
extra pulmonary arteries [16]. Consequently, the slight
decrease in the contraction to ET-1 observed in CH rats
m a yb ee x p l a i n e db yt h ei n t e r m e d i a t es i z eo ft h ep u l -
monary artery (PA) used for the present contractile
experiments (namely PA of the first order or IPA1). In
MCT rats, a recent study has shown that although the
contraction to ET-1 was not altered, ET-B receptors
were decreased in resistance PA [26]. Since the contrac-
tion to ET-1 is linked to ET-A receptors in extra-PA
and to ET-B receptors in IPA [26,27], the present
decreased ET-1 contraction may result from the
reported decrease in ET-B receptors in MCT rats.
Regarding Phe and in contrast to ET-1, we found that
Phe-induced contraction was increased in PA from
MCT rats. A recent report from Mam et al. (2010)
showed a reduced contraction to Phe in CH and MCT
rats [28]. This difference may be explained by different
animal strain (Sprague Dawley vs Wistar rats) and/or
Figure 1 Expression of Cx 37, 40 and 43. A shows mean values ± S.E.M. of relative mRNA expression levels measured by quantitative RT-PCR
in pulmonary arteries from N rats (normoxia, black column, n = 4 - 5), chronic hypoxic rats (chronic hypoxia, white column, n = 9) and
monocrotaline-injected rats (monocrotaline, grey column, n = 5 - 7). B shows protein expression measured by Western Blot and normalized to b
actin expression level in normoxic rats (black column, n = 6 - 12), chronic hypoxic rats (white column, n = 9 - 12) and monocrotaline-injected
rats (grey column, n = 5 - 7). * means a significant difference for P < 0.05.
Billaud et al. Respiratory Research 2011, 12:30
http://respiratory-research.com/content/12/1/30
Page 6 of 13Figure 2 Localization of Cx 37, 40 and 43 in the pulmonary arterial wall. Immunofluorescent labelling experiments shows the presence of
Cx (red) 37 (top row), 40 (middle row) and 43 (bottom row) in transverse sections of pulmonary arteries from normoxic (normoxia, left column),
chronic hypoxic (chronic hypoxia, middle column) and monocrotaline-injected rats (monocrotaline, right column). Green shows the
autofluorescent signal of the vessels and blue shows the nuclei. SMC means smooth muscle cells and EC means endothelial cells. 7-8 normoxic
rats have been used and the number of IPA3 sections, used for the labelling of Cx 37, 40 and 43, was 21, 22 and 14 respectively. 4-5
monocrotaline-injected rats have been used and the number of IPA3 sections, used for the labelling of Cx 37, 40 and 43, was 11, 17 and 14
respectively. Finally, we have used 3 chronic hypoxic rats and the number of IPA3 sections used for the labelling of the Cx 37, 40 and 43, was 4,
5 and 7 respectively. Scale bars are 15 μm.
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different experimental conditions (normobaric vs hypo-
baric hypoxia). Finally, regarding the receptor indepen-
dent depolarizing agent KCl, pulmonary vascular
reactivity to membrane depolarization was increased in
CH rats, whereas it was reduced in MCT rats. These
results are consistent with previous findings from our
laboratory indicating that PA smooth muscle cells
(PASMC) from CH rats exhibit a higher resting mem-
brane potential and a higher basal intracellular calcium
concentration [22,29]. Moreover, the decreased expression
of potassium channels previously observed in CH rats [17]
could also contribute to increase the sensitivity to
depolarisation.
We have previously shown that Cx 37, 40 and 43,
three gap junction proteins commonly found in the vas-
culature, are expressed in rat PA endothelial cells, while
C x3 7a n d4 0o n l ya r ef o u n di nP A S M C[ 1 8 ] .I nt h e
current study, Cx 37, 40 and 43 were also expressed in
pulmonary arterial wall from both hypoxic and non-
h y p o x i cP Hr a t s .H o w e v e r ,P A S M Cf r o mC Hr a t sn o
longer expressed Cx 37 and 40 isoforms, whereas they
Figure 3 Contraction induced by 5-HT, ET-1, Phe and high potassium solutions (KCl). Isometric tension measurements were recorded on
intrapulmonary arteries in response to cumulative concentrations of 5-HT (A, n = 19 - 31), ET-1 (B, n = 17 - 26), Phe (C, n = 21 - 29) and KCl (D,
n = 10 - 20) in normoxic, chronic hypoxic and monocrotaline-injected rats (black, white and grey squares respectively). Data are means ± SEM
and are expressed as a percentage of the high potassium solution (80 mM)-induced response. ** means a significant difference for P < 0.01.
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response to 5-HT. Concentration-response curves to 5-HT were
performed in the absence (control, squares) or in the presence of
connexin-mimetic peptides targeted against Cx 37 and 43 (
37-
43Gap27, circles) and 40 (
40Gap27, triangles). Each set of experiments
was performed on intrapulmonary arteries from normoxic
(normoxia, panel A, black symbols, n = 12 - 24), chronic hypoxic
(chronic hypoxia, panel B, white symbols, n = 8 - 19) and
monocrotaline-injected rats (monocrotaline, panel C, grey symbols,
n = 9 - 20). Data are means ± SEM and are expressed as a
percentage of the high potassium solution (80 mM)-induced
response. * means a significant difference for P < 0.05.
Figure 5 Contribution of Cx 37, 40 and 43 in the contractile
response to ET-1. Concentration-response curves to ET-1 were
performed in the absence (control, squares) or in the presence of
connexin-mimetic peptides targeted against Cx 37 and 43 (
37-
43Gap27, circles) and 40 (
40Gap27, triangles). Each set of experiments
was performed on intrapulmonary arteries from normoxic
(normoxia, panel A, black symbols, n = 10 - 26), chronic hypoxic
(chronic hypoxia, panel B, white symbols, n = 8 - 17) and
monocrotaline-injected rats (monocrotaline, panel C, grey symbols,
n = 8 - 20). Data are means ± SEM and are expressed as a
percentage of the high potassium solution (80 mM)-induced
response.
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Page 9 of 13Figure 6 Contribution of Cx 37, 40 and 43 in the contractile response to Phe. Concentration-response curves to Phe were performed in
the absence (control, squares) or in the presence of connexin-mimetic peptides targeted against Cx 37 and 43 (
37-43Gap27, circles) and 40
(
40Gap27, triangles). Each set of experiments was performed on intrapulmonary arteries from normoxic (normoxia, panel A, black symbols, n = 11
- 21), chronic hypoxic (chronic hypoxia, panel B, white symbols, n = 14 - 23) and monocrotaline-injected rats (monocrotaline, panel D, grey
symbols, n = 7 - 13). Panels C and E summarize the effects of the Gap27 on the contractile changes to Phe from N to CH or from normoxic to
MCT rat models respectively. Data are means ± SEM and are expressed as a percentage of the high potassium solution (80 mM)-induced
response. * means a significant difference for P < 0.05.
Billaud et al. Respiratory Research 2011, 12:30
http://respiratory-research.com/content/12/1/30
Page 10 of 13Figure 7 Contribution of Cx 37, 40 and 43 in the contractile response to high potassium solution (KCl). Concentration-response curves to
KCl were performed in the absence (control, squares) or in the presence of connexin-mimetic peptides targeted against Cx 37 and 43 (
37-
43Gap27, circles) and 40 (
40Gap27, triangles). Each set of experiments was performed on intrapulmonary arteries from normoxic (normoxia, panel
A, black symbols, n = 8 - 20), chronic hypoxic (chronic hypoxia, panel B, white symbols, n = 8 - 20) and monocrotaline-injected rats
(monocrotaline, panel D, grey symbols, n = 4 - 12). Panels C summarizes the effect of the
37-43Gap27 on the contractile changes to KCl from
normoxic to CH rat model. Data are means ± SEM and are expressed as a percentage of the high potassium solution (80 mM)-induced
response. ** means a significant difference for P < 0.01.
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Page 11 of 13were sparsely expressed in MCT rats (Figure 2). Inter-
estingly, Cx 43 expression was upregulated in CH rats
but not in MCT rats (Figure 1). We cannot exclude that
Cx 43 is expressed at the myoendothelial junctions and
possibly on the smooth muscle side of these heterocellu-
lar structures. Cowan et al. have indeed demonstrated
that hypoxia (2.2% O2 during 6 h) increased Cx 43
expression in cultured smooth muscle cells from rat
thoracic aorta [5]. Consequently, we can hypothesize
that the increase in Cx 43 in the IPA from CH rat could
be due to the effect of hypoxia on Cx 43 localized on
the smooth muscle side of the myoendothelial gap junc-
tions. Interestingly, we have previously demonstrated
that Cx 43 present between PASMC and endothelial
cells plays an important role in the vasoreactivity to 5-
HT in IPA from N rats [18].
S i n c e( i )t h et h r e eC x3 7 ,4 0a n d4 3a r ee x p r e s s e di n
CH and MCT rats (Figure 1 and 2) and (ii) Cx 37 and
43 are involved in the contractile and calcium responses
to 5-HT in IPA from N rats [18], we addressed the role
of these Cx in the contractile response to various ago-
nists known to contribute to PH (5-HT, ET-1 and Phe)
in IPA from CH and MCT rats. In the present study,
the effect of Gap27 varied according to the agonists
used and the rat model considered. Since we have pre-
viously demonstrated that the role of the gap junctions
in the contraction depended on the amount of superox-
ide anion (O2
●) level in smooth muscle, it can be
hypothesized that the modulation of O2
●level in IPA
from hypertensive rat models may differ according to
the agonist. In this respect, we can suggest that, unlike
5-HT, Phe increases O2
●levels in pulmonary hyperten-
sive models and not in N rats although this hypothesis
would require further experimental investigation.
Moreover, 5-HT, ET-1 and Phe are pulmonary arterial
vasoconstrictors with different modes of actions. Smooth
muscle contraction is well known to be both dependent
and/or independent on cytosolic calcium increase depend-
ing on the vasoconstrictor. When smooth muscle contrac-
tion is calcium independant, the contraction is due to
calcium sensitization of the contractile proteins. On the
one hand, ET-1 and 5-HT increase intracellular calcium
by acting on receptors localised in both smooth muscle
and endothelial cells (namely 5-HT2A, 5-HT1B/D,E T A and
ETB in PASMC and 5-HT2B and ETB in endothelial cells)
whereas Phe acts on a1-adrenoceptors on PASMC only
[14,21,30,31]. On the other hand, although 5-HT, ET-1
and Phe activate inositol 1,4,5-triphosphate-induced intra-
cellular calcium release, 5-HT and Phe also stimulate vol-
tage-independent calcium permeable channels (namely
receptor- and/or store-operated channels) whereas ET-1
rather stimulates voltage-dependent calcium channels
[32-34]. Finally, contraction to ET-1 and Phe are strongly
dependent on calcium sensitization of contractile proteins
whereas contraction to 5-HT is only slightly dependent on
this process [21,35-37]. Altogether, such differences in the
contractile mechanisms might explain why the effects of
the gap junction blockers differ according to the agonist
used.
Regarding receptor-independent depolarisation, we
have observed a significant decrease in the contraction to
KCl in IPA from MCT rats but an increase in CH rats
(Figure 3D). Moreover,
37-43Gap27 decreased the sensitiv-
ity to high potassium solutions in IPA from CH rats only,
thus inducing a contraction similar to the one observed
in the N rats (Figure 7C). These results suggest that Cx
37 and/or 43 were involved in the hypersensitivity to KCl
in CH rats. This result is thus in good agreement with
the expected role of Cx in the conduction of the electrical
activity observed in various systemic vessels [38].
Conclusions
I nc o n c l u s i o n ,w eh a v ee v i d e n c e dt h ep r e s e n c eo ff u n c -
tional Cx 37, 40 and 43 not only in normal but also in
pathological pulmonary vessels. These three Cx partici-
pate to pulmonary arterial vascular contractility in
response to both receptor-dependent and receptor-inde-
pendent stimuli in N, CH and MCT rats. However, the
role of these Cx in the vasoreactivity of pulmonary
artery varies according to the stimulus and the rat
model. These results suggest that Cx may act as specific
therapeutic targets for different type of PH.
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